COMT polymorphism as a genetic factor in levodopa-induced dyskinesia development in Russian patients with Parkinson's disease

被引：0
|
作者：
Akhmadeeva, G.
Khidiyatova, I.
Gilyazova, I.
Umutbaev, S.
Kachemaeva, O.
Baitimerov, A.
Galimova, R.
Magzhanov, R.
机构：
来源：
MOVEMENT DISORDERS | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1278
引用
收藏
页码：S560 / S561
页数：2
相关论文
共 50 条
  • [41] Levetiracetam (Keppra) in the treatment of levodopa-induced dyskinesia in Parkinson's disease
    Zesiewicz, TA
    Sullivan, KL
    Maldonado, JL
    Tatum, WO
    Hauser, RA
    NEUROLOGY, 2004, 62 (07) : A510 - A510
  • [42] Should there be less emphasis on levodopa-induced dyskinesia in Parkinson's disease?
    Chaudhuri, K. Ray
    Jenner, Peter
    Antonini, Angelo
    MOVEMENT DISORDERS, 2019, 34 (06) : 816 - 819
  • [43] The neural mechanisms underlying levodopa-induced dyskinesia in Parkinson's disease
    Brotchie, JM
    ANNALS OF NEUROLOGY, 2000, 47 (04) : S105 - S114
  • [44] Quantitative electroencephalographic profile of Parkinson's disease with levodopa-induced dyskinesia
    Erickson-Davis, C. R.
    Anderson, J. S.
    Wielinski, C. L.
    Parashos, S. A.
    Krohn, S.
    MOVEMENT DISORDERS, 2008, 23 (01) : S300 - S300
  • [45] Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson’s disease
    Alessandra Nicoletti
    Giovanni Mostile
    Giuseppe Nicoletti
    Gennarina Arabia
    Giovanni Iliceto
    Paolo Lamberti
    Roberto Marconi
    Letterio Morgante
    Paolo Barone
    Aldo Quattrone
    Mario Zappia
    Journal of Neurology, 2016, 263 : 888 - 894
  • [46] Evaluation of the Efficacy of Pramipexole for Treating Levodopa-induced Dyskinesia in Patients with Parkinson's Disease
    Utsumi, Hiroya
    Okuma, Yasuyuki
    Kano, Osamu
    Suzuki, Yutaka
    Iijima, Mutsumi
    Tomimitsu, Hiroyuki
    Hashida, Hideji
    Kubo, Shin-ichiro
    Suzuki, Masahiko
    Nanri, Kazunori
    Matsumura, Miyuki
    Murakami, Hidetomo
    Hattori, Nobutaka
    INTERNAL MEDICINE, 2013, 52 (03) : 325 - 332
  • [47] Levodopa-induced dyskinesia in Parkinson's disease: Epidemiology, etiology, and treatment
    Zesiewicz, Theresa A.
    Sullivan, Kelly L.
    Hauser, Robert A.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2007, 7 (04) : 302 - 310
  • [48] Pathophysiology of levodopa-induced dyskinesia in Parkinson's disease: A TMS study
    Morgante, F
    Espay, AJ
    Gunraj, C
    Lang, AE
    Chen, R
    MOVEMENT DISORDERS, 2005, 20 (09) : 1238 - 1238
  • [49] Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson's disease
    Santos-Lobato, Bruno Lopes
    Schumacher-Schuh, Artur F.
    Rieder, Carlos R. M.
    Hutz, Mara H.
    Borges, Vanderci
    Ferraz, Henrique Ballalai
    Mata, Ignacio F.
    Zabetian, Cyrus P.
    Tumas, Vitor
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2020, 78 (04) : 206 - 216
  • [50] A Web Resource for Levodopa-Induced Dyskinesia Genetics in Parkinson’s Disease
    Hagen Blankenburg
    Marika Falla
    Christine Schwienbacher
    Giovanni Fabbrini
    Alfredo Berardelli
    Peter P. Pramstaller
    Francisco S. Domingues
    Neuroinformatics, 2017, 15 : 297 - 300
12345